Betrixaban scores near miss for extended thromboprophylaxis
Extended thromboprophylaxis with the direct factor Xa inhibitor betrixaban just fails to show superiority to standard treatment with enoxaparin in acutely ill medical patients.
Source: MedWire News - Category: Consumer Health News Tags: Thrombosis Source Type: news